<DOC>
	<DOCNO>NCT02488915</DOCNO>
	<brief_summary>The study objective examine recanalization efficacy EmboTrap device associate performance characteristic record associate clinical outcome manner facilitates relevant comparison output device approve U.S. clear Large Vessel Occlusions .</brief_summary>
	<brief_title>Analysis Revascularization Ischemic Stroke With EmboTrap</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>1 . The patient patient 's legally authorize representative sign date Informed Consent Form . 2 . Aged 18 year 85 year ( inclusive ) . 3 . A new focal disabling neurologic deficit consistent acute cerebral ischemia . 4 . NIHSS score ≥8 ≤25 . 5 . Preictal mRS score 0 1 . 6 . The interventionalist estimate least one deployment EmboTrap device complete within 8 hour onset symptom . 7 . Patients IVtPA indicate available treatment , treat IVtPA . 8 . IVtPA , use , initiate within 3 hr stroke onset ( onset time define last time patient witness baseline ) , investigator verification subject received/is receive correct IV tPA dose estimate weight . 9 . Angiographic confirmation occlusion ICA ( include T L occlusion ) , M1 M2 MCA , VA , BA mTICI flow 0 1 . 10 . For stroke anterior circulation follow image criterion also meet : 1 . MRI criterion : volume diffusion restriction visually assess ≤50 mL . OR 2 . CT criterion : ASPECTS 6 10 baseline CT CTAsource image , , volume significantly lower CBV ≤50 mL . 11 . The patient indicate neurothrombectomy treatment interventionalist confirm diagnostic angiography device able reach target lesion proximally . 1 . Life expectancy likely less 6 month . 2 . Females pregnant breastfeeding . 3 . History severe allergy contrast medium . 4 . Known nickel allergy time treatment . 5 . Known current use cocaine time treatment . 6 . Patient suffer stroke past 3 month . 7 . The patient present NIHSS score &lt; 8 &gt; 25 physician assess clinically relevant uninterrupted coma . 8 . Subject participate another study involve investigational device drug . 9 . Use warfarin anticoagulation Novel Anticoagulant International Normalized Ratio ( INR ) &gt; 3.0 . 10 . Platelet count &lt; 50,000/μL . 11 . Glucose &lt; 50 mg/dL . 12 . Any known hemorrhagic coagulation deficiency . 13 . Unstable renal failure serum creatinine &gt; 3.0 Glomerular Filtration Rate ( GFR ) &lt; 30 . 14 . Patients receive direct thrombin inhibitor within last 48 hour ; must partial thromboplastin time ( PTT ) less 1.5 time normal eligible . 15 . All patient severe hypertension presentation ( SBP &gt; 220mmHg and/or DBP &gt; 120mmHg ) . All patient , intravenous therapy blood pressure medication indicate , hypertension remain severe sustain despite intravenous therapy ( SBP &gt; 185mmHg and/or DBP &gt; 110mmHg ) . . 16 . Known cerebral vasculitis . 17 . Rapidly improve neurological status . 18 . Clinical symptom suggestive bilateral stroke stroke multiple territory . 19 . Ongoing seizure due stroke . 20 . Evidence active systemic infection . 21 . Known cancer metastasis . 22 . Computed tomography ( CT ) Magnetic Resonance Imaging ( MRI ) evidence recent/ fresh hemorrhage presentation . 23 . Baseline compute tomography ( CT ) MRI show mass effect intracranial tumor ( except small meningioma ) . 24 . Suspicion aortic dissection , presume septic embolus , suspicion bacterial endocarditis . 25 . Stenosis , occlusion , proximal vessel require treatment prevents access site occlusion . 26 . Evidence dissection extra intracranial cerebral artery . 27 . Occlusions multiple vascular territory ( e.g. , bilateral anterior circulation , anterior/posterior circulation ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Brain</keyword>
	<keyword>Brain Clot</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Brain Infarction</keyword>
	<keyword>Cerebral Ischemia</keyword>
	<keyword>Cerebrovascular Disorders</keyword>
	<keyword>EmboTrap® Revascularization Device</keyword>
	<keyword>EmboTrap</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Ischemic</keyword>
	<keyword>Ischemic Stroke</keyword>
	<keyword>Mechanical Thrombectomy</keyword>
	<keyword>Neurovascular Intervention</keyword>
	<keyword>Revascularization</keyword>
	<keyword>Stent Retriever</keyword>
	<keyword>Stroke</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Neuravi</keyword>
</DOC>